Fenoglide (Page 7 of 7)

16 HOW SUPPLIED/STORAGE AND HANDLING

FENOGLIDE (fenofibrate) Tablets 40 mg, are white to off-white oval tablets debossed “FLO” on one side and blank on the other side.

Bottle of 90 tablets, NDC 68012-490-90

FENOGLIDE (fenofibrate) Tablets 120 mg, are white to off-white oval tablets debossed “FHI” on one side and blank on the other side.

Bottle of 90 tablets, NDC 68012-495-90

Store at 25°C (77°F); excursions permitted to 15° to 30°C (59° to 86°F) [see USP Controlled Room Temperature].

17 PATIENT COUNSELING INFORMATION

Patients should be advised:

of the potential benefits and risks of FENOGLIDE.
not to use FENOGLIDE if there is a known hypersensitivity to fenofibrate or fenofibric acid.
that if they are taking coumarin anticoagulants, FENOGLIDE may increase their anticoagulant effect, and increased monitoring may be necessary.
of medications that should not be taken in combination with FENOGLIDE.
to continue to follow an appropriate lipid-modifying diet while taking FENOGLIDE.
to take FENOGLIDE once daily, without regard to food, at the prescribed dose, swallowing each tablet whole.
to return to their physician’s office for routine monitoring.
to inform their physician of all medications, supplements, and herbal preparations they are taking and any change to their medical condition. Patients should also be advised to inform their physicians prescribing a new medication that they are taking FENOGLIDE.
to inform their physician of symptoms of liver injury (e.g., jaundice, abnormal pain, nausea, malaise, dark urine, abnormal stool, pruritus); any muscle pain, tenderness, or weakness; onset of abdominal pain; or any other new symptoms.
not to breastfeed during treatment with FENOGLIDE and for 5 days after the final dose.

Distributed by:

Salix Pharmaceuticals, a division of

Bausch Health US, LLC

Bridgewater, NJ 08807 USA

FENOGLIDE is a trademark of Salix Pharmaceuticals, Inc. or its affiliates.

© 2021 Salix Pharmaceuticals, Inc. or its affiliates

U.S. Patent Numbers: 7,658,944; 8,124,125; 8,481,078 and 9,173,847

9606803 70015724

Bottle LABEL – PRINCIPAL DISPLAY PANEL 40MG

NDC 68012-490-90
Fenoglide®
(fenofibrate) Tablets

40 mg

90 Tablets
Rx only
Salix

//medlibrary.org/lib/images-rx/fenoglide/carton-300x148.jpg
(click image for full-size original)

Bottle LABEL – PRINCIPAL DISPLAY PANEL 120MG

NDC 68012-495-90
Fenoglide®

(fenofibrate)

tablets

120 mg

Rx only90 Tablets

Salix

//medlibrary.org/lib/images-rx/fenoglide/label-300x215.jpg
(click image for full-size original)
FENOGLIDE fenofibrate tablet
Product Information
Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:68012-490
Route of Administration ORAL DEA Schedule
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
fenofibrate (FENOFIBRIC ACID) fenofibrate 40 mg
Inactive Ingredients
Ingredient Name Strength
lactose monohydrate
Polyethylene Glycol 6000
Poloxamer 188
magnesium stearate
Product Characteristics
Color white (white) Score no score
Shape OVAL (OVAL) Size 13mm
Flavor Imprint Code FLO
Contains
Packaging
# Item Code Package Description Multilevel Packaging
1 NDC:68012-490-90 90 TABLET in 1 BOTTLE None
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
NDA NDA022118 11/18/2010
FENOGLIDE fenofibrate tablet
Product Information
Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:68012-495
Route of Administration ORAL DEA Schedule
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
fenofibrate (FENOFIBRIC ACID) fenofibrate 120 mg
Inactive Ingredients
Ingredient Name Strength
lactose monohydrate
Polyethylene Glycol 6000
Poloxamer 188
magnesium stearate
Product Characteristics
Color white (white) Score no score
Shape OVAL (OVAL) Size 18mm
Flavor Imprint Code FHI
Contains
Packaging
# Item Code Package Description Multilevel Packaging
1 NDC:68012-495-90 90 TABLET in 1 BOTTLE None
2 NDC:68012-495-07 6 BOTTLE in 1 BOX contains a BOTTLE
2 7 TABLET in 1 BOTTLE This package is contained within the BOX (68012-495-07)
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
NDA NDA022118 11/18/2010
Labeler — Santarus, Inc. (104286369)
Establishment
Name Address ID/FEI Operations
Catalent Pharma Solutions, LLC 829672745 MANUFACTURE (68012-490), MANUFACTURE (68012-495)

Revised: 06/2021 Santarus, Inc.

All MedLibrary.org resources are included in as near-original form as possible, meaning that the information from the original provider has been rendered here with only typographical or stylistic modifications and not with any substantive alterations of content, meaning or intent.

This site is provided for educational and informational purposes only, in accordance with our Terms of Use, and is not intended as a substitute for the advice of a medical doctor, nurse, nurse practitioner or other qualified health professional.

Privacy Policy | Copyright © 2022. All Rights Reserved.